Screener
IHE vs IJR
iShares U.S. Pharmaceuticals ETF vs iShares Core S&P Small-Cap ETF
Key differences
- IJR costs 0.32% less per year.
- IJR is significantly larger than IHE — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, IHE has delivered higher annualized returns.
- IJR has a longer track record, which may reduce uncertainty around long-term behavior.
Side-by-side comparison
| IHE | IJR | |
|---|---|---|
| Annual cost (TER) | 0.38% | 0.06% |
| Fund size (AUM) | $946M | $102.6B |
| Since | 2006 | 2000 |
| Dividend yield | 1.70% | 1.16% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +46.2% | +33.1% |
| CAGR 3Y | +18.0% | +15.4% |
| CAGR 5Y | +10.1% | +5.9% |
| Sharpe 3Y | 0.87 | 0.63 |
| Volatility 1Y | 16.91% | 17.65% |
| Max drawdown | -29.59% | -44.36% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to IHE and IJR
Explore further